388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors :: Library Catalog

library@stipram.ac.id (0274) 485 650

Pengumuman Berita Terbaru PMB

388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors

oleh: Jack Li

Format:	Article
Diterbitkan:	BMJ Publishing Group 2020-11-01

Deskripsi

No description available for this item.